242 related articles for article (PubMed ID: 33181717)
1. Establishment of immune prognostic signature and analysis of prospective molecular mechanisms in childhood osteosarcoma patients.
Zhang Z; Liu C; Liang T; Yu C; Qin Z; Zhou X; Xue J; Zeng H; Lu Z; Xu G; Wang Z; Chen J; Jiang J; Zhan X
Medicine (Baltimore); 2020 Nov; 99(46):e23251. PubMed ID: 33181717
[TBL] [Abstract][Full Text] [Related]
2. Development of an immune-related prognostic index associated with osteosarcoma.
Yin CD; Hou YL; Liu XR; He YS; Wang XP; Li CJ; Tan XH; Liu J
Bioengineered; 2021 Dec; 12(1):172-182. PubMed ID: 33371790
[TBL] [Abstract][Full Text] [Related]
3. Identification and Validation of a Potent Multi-miRNA Signature for Prediction of Prognosis of Osteosarcoma Patients.
Luo X; Tang J; Xuan H; Liu J; Li X
Med Sci Monit; 2020 Feb; 26():e919272. PubMed ID: 32098942
[TBL] [Abstract][Full Text] [Related]
4. Importance of CD8 Tex cell-associated gene signatures in the prognosis and immunology of osteosarcoma.
Lu Y; Cao N; Zhao M; Zhang G; Zhang Q; Wang L
Sci Rep; 2024 Apr; 14(1):9769. PubMed ID: 38684858
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance and prospective molecular mechanism of C‑C motif chemokine receptors in patients with early‑stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy.
Zhou X; Liao X; Wang X; Huang K; Yang C; Yu T; Liu J; Han C; Zhu G; Su H; Qin W; Han Q; Liu Z; Huang J; Gong Y; Ye X; Peng T
Oncol Rep; 2019 Nov; 42(5):1856-1868. PubMed ID: 31432181
[TBL] [Abstract][Full Text] [Related]
6. A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy.
Pan R; Pan F; Zeng Z; Lei S; Yang Y; Yang Y; Hu C; Chen H; Tian X
Front Immunol; 2022; 13():1017120. PubMed ID: 36189307
[TBL] [Abstract][Full Text] [Related]
7. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
[TBL] [Abstract][Full Text] [Related]
8. Construction and validation of a novel gene signature for predicting the prognosis of osteosarcoma.
Yang J; Zhang A; Luo H; Ma C
Sci Rep; 2022 Jan; 12(1):1279. PubMed ID: 35075228
[TBL] [Abstract][Full Text] [Related]
9. Development of a novel immune-related genes prognostic signature for osteosarcoma.
Wu ZL; Deng YJ; Zhang GZ; Ren EH; Yuan WH; Xie QQ
Sci Rep; 2020 Oct; 10(1):18402. PubMed ID: 33110201
[TBL] [Abstract][Full Text] [Related]
10. A Novel Immune-Related Prognostic Signature for Thyroid Carcinoma.
Xue Y; Li J; Lu X
Technol Cancer Res Treat; 2020; 19():1533033820935860. PubMed ID: 32588760
[TBL] [Abstract][Full Text] [Related]
11. Expression of immune-related genes as prognostic biomarkers for the assessment of osteosarcoma clinical outcomes.
Guo J; Li X; Shen S; Wu X
Sci Rep; 2021 Dec; 11(1):24123. PubMed ID: 34916564
[TBL] [Abstract][Full Text] [Related]
12. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma cancer.
Liu R; Hu Y; Liu T; Wang Y
BMC Cancer; 2021 Dec; 21(1):1345. PubMed ID: 34922489
[TBL] [Abstract][Full Text] [Related]
13. Development of a prognostic gene signature based on an immunogenomic infiltration analysis of osteosarcoma.
Yu Y; Zhang H; Ren T; Huang Y; Liang X; Wang W; Niu J; Han Y; Guo W
J Cell Mol Med; 2020 Oct; 24(19):11230-11242. PubMed ID: 32820615
[TBL] [Abstract][Full Text] [Related]
14. Establishment of an Autophagy-Related Clinical Prognosis Model for Predicting the Overall Survival of Osteosarcoma.
Li J; Tang X; Du Y; Dong J; Zhao Z; Hu H; Song T; Guo J; Wang Y; Xu T; Shao C; Sheng Y; Xi Y
Biomed Res Int; 2021; 2021():5428425. PubMed ID: 34604383
[TBL] [Abstract][Full Text] [Related]
15. Identification of TNFRSF1A as a potential biomarker for osteosarcoma.
Zhang Y; Liu K; Wang J
Cancer Biomark; 2024; 39(4):299-312. PubMed ID: 38250759
[TBL] [Abstract][Full Text] [Related]
16. 12 Survival-related differentially expressed genes based on the TARGET-osteosarcoma database.
Rothzerg E; Xu J; Wood D; Kõks S
Exp Biol Med (Maywood); 2021 Oct; 246(19):2072-2081. PubMed ID: 33926256
[TBL] [Abstract][Full Text] [Related]
17. A five-gene signature may predict sunitinib sensitivity and serve as prognostic biomarkers for renal cell carcinoma.
Chen YL; Ge GJ; Qi C; Wang H; Wang HL; Li LY; Li GH; Xia LQ
J Cell Physiol; 2018 Oct; 233(10):6649-6660. PubMed ID: 29327492
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
[TBL] [Abstract][Full Text] [Related]
19. Signature constructed by glycolysis-immune-related genes can predict the prognosis of osteosarcoma patients.
Tian K; Qi W; Yan Q; Lv M; Song D
Invest New Drugs; 2022 Aug; 40(4):818-830. PubMed ID: 35435626
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel glycolysis-related gene signature for predicting the prognosis of osteosarcoma patients.
Yang M; Ma X; Wang Z; Zhang T; Hua Y; Cai Z
Aging (Albany NY); 2021 May; 13(9):12896-12918. PubMed ID: 33952718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
